For the first time, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers regardless of where they originated – breast, prostate, liver, lung. The drugs go after an aberration involving a cancer gene fundamental to tumor growth. Many scientists see this as beginning a new genetic age in cancer research. Great uncertainties remain, but such drugs could mean new treatments for rare, neglected cancers, as well as common ones. Merck, Roche and Sanofi are racing to develop versions of a drug they hope will restore a mechanism that normally makes badly damaged cells self-destruct and could potentially be used against half of all cancers....
0 Responses to Drug firms hope new drugs can fight multiple cancers - Health and Medicine - The ...